On the upside
National Traders Association issued a research report on Keryx Biopharmaceuticals (NYSE: KERX) saying that upcoming marketing approval for the company's kidney disease treatment Zerenex will improve company outlook.
Fourth quarter earnings rose for IBM (NYSE: IBM) to top analyst estimates.
On the downside
TheStreet reported that Star Scientific (Nasdaq: STSI) deceived investors by implying that John Hopkins was involved in one of its clinical tests. Tata Motors (NYSE: TATA) reported that growth slowed at its Jaguar Land Rover division.
Profit taking sank shares of Synovus Financial (NYSE: SNV).
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE and by more than 9 to 7 on Nasdaq. The broader S&P 500 index added a point to 1493.